ACE and chronic kidney disease: Additional data on diabetes, chronic kidney disease, and standard baseline treatments (ACE inhibitors/ARBs, beta-blockers, and diuretics) were included, as these could influence outcomes and provide a more comprehensive understanding of the study population.